In the October 2017 issue of JOGC, the legend in Table 1 of the commentary on screening in the antenatal care process
1
should have been:NPV: probability that subjects with a negative screen do not have the disease D/(C + D).
Reference
- Informed consent for screening in the antenatal care process: are we really counselling patients to allow an informed understanding and “real” consent?.J Obstet Gynaecol Can. 2017; 39: 919-921
Article info
Identification
Copyright
Copyright © 2018 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Informed Consent for Screening in the Antenatal Care Process: Are We Really Counselling Patients to Allow an Informed Understanding and “Real” Consent?Journal of Obstetrics and Gynaecology Canada Vol. 39Issue 10
- PreviewThe “age of genomic health/medicine screening” is being introduced into prenatal care through the prenatal genetic screening programs. The discussion and rigor that is expected by the industry and the provider for this genomic screening—in both the pre- and post-test arenas—for a patient-informed consent process is extensive.
- Full-Text
- Preview
